Monte Rosa Therapeutics I... (GLUE)
NASDAQ: GLUE
· Real-Time Price · USD
4.90
-0.01 (-0.20%)
At close: May 01, 2025, 3:59 PM
4.90
0.00%
After-hours: May 01, 2025, 04:20 PM EDT
Monte Rosa Therapeutics Revenue
Monte Rosa Therapeutics reported an annual revenue of $75.62M, reflecting a 0% growth. For the quarter ending December 31, 2024, Monte Rosa Therapeutics generated $60.65M in revenue.
Revenue (ttm)
$75.62M
Revenue Growth
0%
Price / Sales Ratio
6.78
Revenue / Employee
$564.34K
Employees
134
Market Cap
301.4M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 75.62M | +Infinity% |
| Dec 31, 2023 | 0 | n/a |
| Dec 31, 2022 | 0 | n/a |
| Dec 31, 2021 | 0 | n/a |
| Dec 31, 2020 | 0 | n/a |